Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

23,607 total articles

TransUnion Extends 99-Cent Mortgage Pricing for VantageScore® 4.0 Through the End of 2028 to Support Competition and Price Stability in Mortgage Credit Scoring

TransUnion Extends 99-Cent Mortgage Pricing for VantageScore® 4.0 Through the End of 2028 to Support Competition and Price Stability in Mortgage Credit Scoring

TransUnion announced it will continue offering the VantageScore 4.0 mortgage credit score at $0.99 per origination through December 2028, providing pricing stability and supporting wider adoption among lenders. This extension follows regulatory expansions allowing greater use of VantageScore 4.0 by Fannie Mae, Freddie Mac, and FHA, enhancing credit…

ThredUp Expands Into Live Shopping with Whatnot

ThredUp Expands Into Live Shopping with Whatnot

ThredUp announced its expansion into the live shopping market by launching live shows on Whatnot, the leading live commerce platform across the US, UK, and Europe. Starting from its distribution centers in Atlanta and Dallas, ThredUp aims to tap into the $22 billion live shopping market by offering millions of curated secondhand fashion items. The …

Credit Card Application Fraud Climbs as Identity Thieves Disproportionately Target Canadians Aged 56 to 65

Credit Card Application Fraud Climbs as Identity Thieves Disproportionately Target Canadians Aged 56 to 65

Equifax Canada's latest Market Pulse reveals a notable 8% year-over-year increase in credit card application fraud in Q2 2026, primarily due to third-party identity theft. The fraud rise contrasts declines in auto, mortgage, and telecom applications. Canadians aged 56-65 are disproportionately targeted, exploiting their higher credit limits and les…

Caspian Therapeutics Unveils KO-7246 at EASD as a Potential Best-In-Class Menin Inhibitor for Diabetes

Caspian Therapeutics Unveils KO-7246 at EASD as a Potential Best-In-Class Menin Inhibitor for Diabetes

Caspian Therapeutics and Kura Oncology announced preclinical data for KO-7246, a selective menin inhibitor that promotes beta-cell regeneration, durable glycemic control, and increased endogenous insulin production in Type 1 and Type 2 diabetes models. The compound shows potential as a disease-modifying therapy, complementing existing treatments li…

Willis launches RiskIQ Nexus, giving organizations a single trusted view of risk and insurance data to drive greater value

Willis launches RiskIQ Nexus, giving organizations a single trusted view of risk and insurance data to drive greater value

Willis Towers Watson (NASDAQ: WTW) has launched RiskIQ Nexus, an AI-enabled risk intelligence platform that consolidates risk and insurance data from multiple sources into a single view. The tool aims to improve risk managers' ability to analyze policies, premiums, losses, and exposure data efficiently, supporting more informed insurance decision-m…

Pharming announces CEO transition

Pharming announces CEO transition

Pharming Group N.V. announced the immediate departure of CEO Fabrice Chouraqui due to strategic differences with the Board. Interim co-CEOs Leverne Marsh and Kenneth Lynard have been appointed to ensure leadership continuity while a permanent successor is sought. The company reaffirmed its commitment to its strategic priorities and patient-focused …

EHang’s Global Fast Track Program Expands to Vietnam, Its Second Country, Joining Hands with Hanoi to Build a Low‑Altitude Sandbox

EHang’s Global Fast Track Program Expands to Vietnam, Its Second Country, Joining Hands with Hanoi to Build a Low‑Altitude Sandbox

EHang Holdings Limited (Nasdaq: EH), a leader in Advanced Air Mobility technology, announced the expansion of its Global Fast Track Program to Vietnam, marking Hanoi as its first city-level partner. The company signed a Memorandum of Understanding with Hanoi's Department of Science and Technology and local partner HungViet Technology to conduct low…

NewGen Announces Pricing of $1.25 Million Public Offering

NewGen Announces Pricing of $1.25 Million Public Offering

NewGenIvf Group Limited (NASDAQ: NIVF) announced the pricing of a $1.25 million public offering consisting of 17.86 million ordinary shares and pre-funded warrants at $0.07 per share. Proceeds will be used for investing in AI ventures, restructuring debt, expanding manufacturing in cell-sorting technology, and general corporate needs. The offering …

Julong Holding Limited Announces Private Placement

Julong Holding Limited Announces Private Placement

Julong Holding Limited, a Nasdaq-listed provider of intelligent integrated solutions, has entered into a securities purchase agreement to issue 750,000 Class A ordinary shares and 2,250,000 pre-funded warrants, generating gross proceeds of approximately $897,750. The funds raised will be used for general corporate purposes. The private placement is…

Quantum-Si Presents Interim Proteus™ Data at World HUPO 2026 Demonstrating a Significant Step Change in Performance Compared to Platinum® Pro

Quantum-Si Presents Interim Proteus™ Data at World HUPO 2026 Demonstrating a Significant Step Change in Performance Compared to Platinum® Pro

Quantum-Si released interim data demonstrating that its next-generation Proteus™ platform significantly outperforms its current Platinum® Pro instrument in protein sequencing scale, accuracy, and peptide identification. Despite still being in development, Proteus showed up to 30 times more alignments per chamber, markedly lower false discovery rate…

HUTCHMED Announces Submission of US NDA for ORPATHYS® plus TAGRISSO® in MET-Driven EGFR-Mutated Lung Cancer

HUTCHMED Announces Submission of US NDA for ORPATHYS® plus TAGRISSO® in MET-Driven EGFR-Mutated Lung Cancer

HUTCHMED, in collaboration with AstraZeneca, has submitted a New Drug Application to the US FDA for the combination of ORPATHYS (savolitinib) and TAGRISSO (osimertinib) for advanced non-small cell lung cancer (NSCLC) patients with MET overexpression or amplification after progression on EGFR-TKI therapy. The NDA is supported by the global SAFFRON P…

AIRE Inc. Announces Entering into an Agreement and Plan of Merger with OceanLight Acquisition Corporation

AIRE Inc. Announces Entering into an Agreement and Plan of Merger with OceanLight Acquisition Corporation

AIRE Inc., a home textile and green sleep technology company, has entered an agreement to merge with OceanLight Acquisition Corporation, a Nasdaq-listed special purpose acquisition company (SPAC). This transaction will take AIRE public with an implied company valuation of $1 billion, providing it greater access to capital markets to support growth,…

TTEC Digital achieves the 2026-2027 Microsoft AI Business Solutions Inner Circle award for 11th consecutive year

TTEC Digital achieves the 2026-2027 Microsoft AI Business Solutions Inner Circle award for 11th consecutive year

TTEC Digital has received the prestigious Microsoft AI Business Solutions Inner Circle award for the 2026-2027 period, marking the eleventh consecutive year of this recognition. This award places TTEC Digital among the top global partners of Microsoft in AI business solutions, reflecting the company's strong sales performance and expertise in deliv…